These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33091761)

  • 1. Lyophilized fecal short-chain fatty acid and electrolyte determination by capillary electrophoresis with indirect UV detection for assessment of pediatric inflammatory bowel disease.
    Lemay JA; Yamamoto M; Kroezen Z; Shanmuganathan M; Ly R; Hart L; Pai N; Britz-McKibbin P
    J Pharm Biomed Anal; 2021 Jan; 192():113658. PubMed ID: 33091761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity.
    Tews HC; Elger T; Gunawan S; Fererberger T; Sommersberger S; Loibl J; Huss M; Liebisch G; Müller M; Kandulski A; Buechler C
    Lipids Health Dis; 2023 Oct; 22(1):164. PubMed ID: 37789460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal short-chain fatty acids in children with inflammatory bowel disease.
    Treem WR; Ahsan N; Shoup M; Hyams JS
    J Pediatr Gastroenterol Nutr; 1994 Feb; 18(2):159-64. PubMed ID: 8014762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.
    Parada Venegas D; De la Fuente MK; Landskron G; González MJ; Quera R; Dijkstra G; Harmsen HJM; Faber KN; Hermoso MA
    Front Immunol; 2019; 10():277. PubMed ID: 30915065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease.
    Zhuang X; Li T; Li M; Huang S; Qiu Y; Feng R; Zhang S; Chen M; Xiong L; Zeng Z
    Inflamm Bowel Dis; 2019 Oct; 25(11):1751-1763. PubMed ID: 31498864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 16S sequencing and functional analysis of the fecal microbiome during treatment of newly diagnosed pediatric inflammatory bowel disease.
    Ashton JJ; Colquhoun CM; Cleary DW; Coelho T; Haggarty R; Mulder I; Batra A; Afzal NA; Beattie RM; Scott KP; Ennis S
    Medicine (Baltimore); 2017 Jun; 96(26):e7347. PubMed ID: 28658154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease is associated with increased gut-to-blood penetration of short-chain fatty acids: A new, non-invasive marker of a functional intestinal lesion.
    Jaworska K; Konop M; Bielinska K; Hutsch T; Dziekiewicz M; Banaszkiewicz A; Ufnal M
    Exp Physiol; 2019 Aug; 104(8):1226-1236. PubMed ID: 31243807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.
    Svolos V; Hansen R; Nichols B; Quince C; Ijaz UZ; Papadopoulou RT; Edwards CA; Watson D; Alghamdi A; Brejnrod A; Ansalone C; Duncan H; Gervais L; Tayler R; Salmond J; Bolognini D; Klopfleisch R; Gaya DR; Milling S; Russell RK; Gerasimidis K
    Gastroenterology; 2019 Apr; 156(5):1354-1367.e6. PubMed ID: 30550821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of intestinal inflammation (IBD) and small and large bowel length on fecal short-chain fatty acids and lactate.
    Hove H; Mortensen PB
    Dig Dis Sci; 1995 Jun; 40(6):1372-80. PubMed ID: 7781463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of metabolites levels in feces of patients with inflammatory bowel diseases].
    Zhgun ES; Kislun YV; Kalachniuk TN; Veselovsky VA; Urban AS; Tikhonova PO; Pavlenko AV; Ilchenko GN; Ilina EN
    Biomed Khim; 2020 May; 66(3):233-240. PubMed ID: 32588829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
    Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and Optimization of Sample Handling Methods for Quantification of Short-Chain Fatty Acids in Human Fecal Samples by GC-MS.
    Hsu YL; Chen CC; Lin YT; Wu WK; Chang LC; Lai CH; Wu MS; Kuo CH
    J Proteome Res; 2019 May; 18(5):1948-1957. PubMed ID: 30895795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Freeze-drying enables homogeneous and stable sample preparation for determination of fecal short-chain fatty acids.
    Ueyama J; Oda M; Hirayama M; Sugitate K; Sakui N; Hamada R; Ito M; Saito I; Ohno K
    Anal Biochem; 2020 Jan; 589():113508. PubMed ID: 31751532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
    Levine A; Wine E; Assa A; Sigall Boneh R; Shaoul R; Kori M; Cohen S; Peleg S; Shamaly H; On A; Millman P; Abramas L; Ziv-Baran T; Grant S; Abitbol G; Dunn KA; Bielawski JP; Van Limbergen J
    Gastroenterology; 2019 Aug; 157(2):440-450.e8. PubMed ID: 31170412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-chain fatty acid levels in stools of patients with inflammatory bowel disease are lower than those in healthy subjects.
    Ozturk O; Celebi G; Duman UG; Kupcuk E; Uyanik M; Sertoglu E
    Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):890-896. PubMed ID: 38829943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal short-chain fatty acid concentrations and dysbiosis in dogs with chronic enteropathy.
    Minamoto Y; Minamoto T; Isaiah A; Sattasathuchana P; Buono A; Rangachari VR; McNeely IH; Lidbury J; Steiner JM; Suchodolski JS
    J Vet Intern Med; 2019 Jul; 33(4):1608-1618. PubMed ID: 31099928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography-tandem mass spectrometry.
    Han J; Lin K; Sequeira C; Borchers CH
    Anal Chim Acta; 2015 Jan; 854():86-94. PubMed ID: 25479871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease.
    Tjellström B; Högberg L; Stenhammar L; Magnusson KE; Midtvedt T; Norin E; Sundqvist T
    Scand J Gastroenterol; 2012 Dec; 47(12):1454-9. PubMed ID: 23016828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease.
    Danilova NA; Abdulkhakov SR; Grigoryeva TV; Markelova MI; Vasilyev IY; Boulygina EA; Ardatskaya MD; Pavlenko AV; Tyakht AV; Odintsova AK; Abdulkhakov RA
    Ter Arkh; 2019 May; 91(4):17-24. PubMed ID: 31094471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.